colorectal-cancer

Documents about colorectal-cancer

• <b>Prediction of Postoperative Recurrence in Stage II–III Colorectal Cancer Using a Machine Learning Model Based on CCDC154 Expression and Clinicopathological Features</b>#264776Figshare
• The BEVATOMOX phase II trial: raltitrexed/oxaliplatin/bevacizumab vs mFOLFOX6/bevacizumab in 2nd-line metastatic colorectal cancer#311896HAL (France)
• Reimagining Nodal Staging in Colorectal Cancer: Toward a Novel Non-Invasive Imaging Approach#357598HAL (France)
• Clinical, Radiologic, and Surgical Features of Brain Metastases in Colorectal Cancer. A Strong Correlation Between Surgical Patterns and Outcome#468476IRIS
• The role of adhesins of &lt;i&gt;Fusobacterium nucleatum&lt;/i&gt; in colorectal cancer - a structural perspective#651922Europe PMC
• Study to Assess the Effect of Consumption of Fish Oil Encapsulated on Inflammatory Markers in Colorectal Cancer#802666ClinicalTrials.gov
• Clinical Efficacy Evaluation of a Computer-aided Colonoscopy as Compared With the Standard Colonoscopy.#813653ClinicalTrials.gov
• Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Fluorouracil#829962ClinicalTrials.gov
• A Study on a Blood-based Dual-target Test for CRC Detection#805536ClinicalTrials.gov
• A Screening Study Targeting Tumor-specific Antigens#238092ClinicalTrials.gov
• Microbial Invasion and Immunosuppression Drives Adenoma Progression in Early Colorectal Cancer Development#444933bioRxiv / medRxiv
• Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer#411393ClinicalTrials.gov
• Is the significant risk of perioperative complications associated with radical surgery following non-curative endoscopic submucosal dissection for early colorectal cancer still acceptable?#418042IRIS
• Assessing the role of ultra-processed foods in colorectal cancer incidence: insights from the EPIC cohort#218192HAL (France)
• Analysis of Histopathological Factors Predictive of Lymph Node Involvement and Management Practices in pT1 Colorectal Cancers Treated by Primary Endoscopic Resection#825300ClinicalTrials.gov
• Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012#6814OpenAlex
• Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA#67893ClinicalTrials.gov
• A Study of a Personalized Neoantigen Cancer Vaccine#314340ClinicalTrials.gov
• SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation#826598ClinicalTrials.gov
• The IMPETUS Cancer Trial. A Technology Delivered Physical Activity Intervention in Cancer#828509ClinicalTrials.gov
• Envafolimab as Neoadjuvant Immuntherapy in Resectable Local Advanced dMMR/MSI-H Colorectal Cancer#123476ClinicalTrials.gov
• The "oral-gut axis" transmission of microorganisms in colorectal cancer: Insights from &lt;i&gt;Peptostreptococcus'&lt;/i&gt; perspective#253494Europe PMC
• Association between glucagon-like peptide-1 receptor agonists and colorectal cancer survival: A population-based cohort study#304655HAL (France)
• The Effect of Oncogenic Alterations on Phenotype Profiles in Colorectal Cancer Cells – a Pooled Single-Cell Screen#322212edoc-Server
• Intratumoral enrichment and suppressive activity of DP8α regulatory T cells in human colorectal cancer#344341HAL (France)
• Elevated serum levels of proinflammatory cytokines potentially correlate with depression and anxiety in colorectal cancer patients in different stages of the antitumor therapy#385556Repositório Institucional Unesp
• Discoidin domain receptor 1 contributes to colorectal cancer progression by promoting cell migration and invasion#388246HAL (France)
• Diagnostic Value of Diffusion-weighted Magnetic Resonance in High-risk Colorectal and Appendiceal Neoplasms#804359ClinicalTrials.gov
• Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer#804853ClinicalTrials.gov
• Intra Peritoneal Chemo Hyperthermia (IPCH) : Cellular and Metabolic Consequences#813081ClinicalTrials.gov
• Research data for article: Mutual impact of adipocytes and colorectal cancer cells growing in co-culture conditions#647359RepOD Dataverse OAI Archive
• Sex ratio disparities in the two most common cancers worldwide: an exploratory analysis using GLOBOCAN 2022 data, gender inequalities, and economic indicators#13218HAL (France)
• Evaluation of surgical stress after colorectal interventions: a multicenter randomized clinical trial of robotic versus laparoscopic surgery#456863IRIS
• Comparison of Primovist-enhanced MRI, Diffusion Weighted MRI and Multidetector CT of Colorectal Liver Metastases#806453ClinicalTrials.gov
• Incidence and Risk Factors of Low Anterior Resection Syndrome#394670ClinicalTrials.gov
• T Regulatory Lymphocytes (Treg) Depletion for Cancer Treatment Efficacy and Safety Study#633717ClinicalTrials.gov
• Biostatistical applications and omics data integration in digestive cancers#239032HAL (France)
• LDRT Sequential NIPS Immunochemotherapy for Peritoneal Metastasis of Gastric and Colorectal Cancer#234427ClinicalTrials.gov
• Using colorectal cancer screening evidence to stratify for personal risk among those with a family history of colorectal cancer: a 42-year cohort study#343634bioRxiv / medRxiv
• Adjuvant Durvalumab Plus Regorafenib vs Untreated Control in Stage IV Colorectal Cancer Patients With no Evidence of Disease (NED): VIVA Trial#373611ClinicalTrials.gov
• Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy#811779ClinicalTrials.gov
• A Study of FOLFIRI Plus OMP-21M18 as 1st or 2nd-line Treatment in Subjects With Metastatic Colorectal Cancer#812099ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract#226346ClinicalTrials.gov
• A Phase II Study of Sintilimab Combined With Ipilimumab N01, Cetuximab and Dabrafenib in Patients With Microsatellite-Stable, BRAF V600E-Mutated Metastatic Colorectal Cancer#279522ClinicalTrials.gov
• Anti-proliferative and cytotoxic effects of CBD and CBDA in human colorectal cancer#456145University of Nottingham Repository
• The Effects of a Food Product Containing Mushroom Extracts (AndoSanTM) in Subjects With Colorectal Cancer-related Fatigue#802883ClinicalTrials.gov
• SAMe in Prevention of Oxaliplatin-associated Liver Injury#807329ClinicalTrials.gov
• Microsatellite Instability in Colorectal Cancers#813432ClinicalTrials.gov
• Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer#363615ClinicalTrials.gov
• Social Prescriptions and Micro-Learning to Improve Care for Cancer Patients and Their Support Persons#810211ClinicalTrials.gov